• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期和复发性结直肠癌患者 CapeOX 治疗团队管理方法的观察性研究:SMILE 研究(转移性结直肠癌学习效应影响研究)

An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect).

作者信息

Matsuoka Hiroshi, Ogata Yutaka, Nakamura Michio, Shibata Yoshihisa, Munemoto Yoshinori, Bando Hiroyuki, Nishijima Koji, Okuda Hiroyuki, Terada Itsuro, Shiroiwa Takeru, Kishimoto Junji, Maeda Kotaro

机构信息

Department of Surgery, Fujita Health University, Toyoake, Japan.

Department of Surgery, Kurume University, Kurume, Japan.

出版信息

J Anus Rectum Colon. 2020 Apr 28;4(2):79-84. doi: 10.23922/jarc.2019-020. eCollection 2020.

DOI:10.23922/jarc.2019-020
PMID:32346646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7186009/
Abstract

OBJECTIVES

In recent years, CapeOX therapy for patients with colorectal cancer is widely used. We previously reported that a multidisciplinary approach decreases the worsening of adverse events and increases patient satisfaction. In this study, we conducted a multicenter, prospective, observational study to evaluate the incidence of adverse events, health-related quality of life (HRQOL) of the patient, and efficacy of a management (intervention) according to the support system (SMILE study).

METHODS

As the interventional method, the following more than one method was carried out in each institute, 1: support with telephone, 2: dosing instruction by a pharmacist, 3: skin care instruction by a nurse, and 4: patient instruction by a doctor. The primary endpoint was the incidence of hand-foot syndrome (HFS) of more than grade 2. The secondary endpoint was the HRQOL evaluation and efficacy. The questionnaire (HADS) was administered before the start of the chemotherapy and in 1, 2, 4, 5, and 8 courses to evaluate quality of life (QOL).

RESULTS

From April 2011 to September 2012, 80 patients were enrolled from 14 sites, and all patients were the subjects of analysis. The demographic background was as follows: man/woman: 46/34, age median: 63 (36-75), and management interventional method 1/2/3/4: 36/68/73/78. The overall percentage of HFS that exceeded grade 2 within 6 months was 16.3%. It was 11.1% with the telephone support group and 20.5% without the telephone support group (p = 0.26).

CONCLUSIONS

A multi-professional telephone support may reduce the deterioration of HFS. Further study which includes larger cohort is needed in the future.

摘要

目的

近年来, CapeOX方案在结直肠癌患者中广泛应用。我们之前报道多学科方法可减少不良事件的恶化并提高患者满意度。在本研究中,我们进行了一项多中心、前瞻性观察研究,以评估不良事件的发生率、患者的健康相关生活质量(HRQOL)以及根据支持系统进行管理(干预)的效果(SMILE研究)。

方法

作为干预方法,各机构采用以下一种以上方法:1:电话支持;2:药剂师进行剂量指导;3:护士进行皮肤护理指导;4:医生进行患者指导。主要终点是2级以上手足综合征(HFS)的发生率。次要终点是HRQOL评估和效果。在化疗开始前以及第1、2、4、5和8疗程时进行问卷调查(HADS)以评估生活质量(QOL)。

结果

2011年4月至2012年9月,从14个地点招募了80例患者,所有患者均为分析对象。人口统计学背景如下:男/女:46/34,年龄中位数:63(36 - 75),管理干预方法1/2/3/4:36/68/73/78。6个月内HFS超过2级的总体百分比为16.3%。电话支持组为11.1%,无电话支持组为20.5%(p = 0.26)。

结论

多专业电话支持可能会减少HFS的恶化。未来需要纳入更大队列的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/7186009/c32795312d59/2432-3853-4-0079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/7186009/1b845a1762a2/2432-3853-4-0079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/7186009/c32795312d59/2432-3853-4-0079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/7186009/1b845a1762a2/2432-3853-4-0079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/7186009/c32795312d59/2432-3853-4-0079-g002.jpg

相似文献

1
An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect).晚期和复发性结直肠癌患者 CapeOX 治疗团队管理方法的观察性研究:SMILE 研究(转移性结直肠癌学习效应影响研究)
J Anus Rectum Colon. 2020 Apr 28;4(2):79-84. doi: 10.23922/jarc.2019-020. eCollection 2020.
2
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.S-1 联合奥沙利铂对比卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者的随机、非劣效性 3 期临床试验。
Lancet Oncol. 2012 Nov;13(11):1125-32. doi: 10.1016/S1470-2045(12)70363-7. Epub 2012 Oct 10.
3
Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.口服胱氨酸和茶氨酸对结直肠癌术后接受以卡培他滨为基础的辅助化疗患者的疗效:一项多机构、随机、双盲、安慰剂对照的II期试验研究方案
BMJ Open. 2018 Jul 19;8(7):e021442. doi: 10.1136/bmjopen-2017-021442.
4
Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.TRICOLORE试验的研究方案:一项关于奥沙利铂为基础的化疗与S-1、伊立替康和贝伐单抗联合化疗作为转移性结直肠癌一线治疗的随机III期研究。
BMC Cancer. 2015 Sep 9;15:626. doi: 10.1186/s12885-015-1630-1.
5
Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03).口服胱氨酸和茶氨酸对术后接受以卡培他滨为基础的辅助化疗的结直肠癌患者的疗效:一项多机构、随机、双盲、安慰剂对照的II期试验(JORTC-CAM03)
Support Care Cancer. 2020 Aug;28(8):3649-3657. doi: 10.1007/s00520-019-05205-1. Epub 2019 Dec 6.
6
[Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy].[对接受化疗的癌症门诊患者手足综合征的评估]
Gan To Kagaku Ryoho. 2012 Dec;39 Suppl 1:74-6.
7
[Trans-sectoral care for patients with colorectal cancer: Design of a prospective randomized controlled multi-center trial (FKZ 01GY1143)].[结直肠癌患者的跨部门护理:一项前瞻性随机对照多中心试验的设计(项目编号01GY1143)]
Z Evid Fortbild Qual Gesundhwes. 2015;109(2):171-80. doi: 10.1016/j.zefq.2014.06.012. Epub 2014 Aug 28.
8
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group.S-1 对比卡培他滨用于转移性结直肠癌一线治疗的随机 III 期临床试验:荷兰结直肠癌研究组 SALTO 研究。
Ann Oncol. 2017 Jun 1;28(6):1288-1293. doi: 10.1093/annonc/mdx122.
9
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.微卫星不稳定高或错配修复缺陷转移性结直肠癌患者一线帕博利珠单抗与化疗治疗的健康相关生活质量(KEYNOTE-177):一项开放标签、随机、III 期试验。
Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1.
10
[Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy].[接受含卡培他滨化疗的癌症患者手足综合征的评估]
Gan To Kagaku Ryoho. 2013 Dec;40 Suppl 2:161-3.

引用本文的文献

1
Evaluation of the impact of systemic dexamethasone dosage on docetaxel-induced hand-foot syndrome in patients with breast cancer.评估全身给予地塞米松剂量对乳腺癌患者多西紫杉醇所致手足综合征的影响。
Sci Rep. 2024 Jun 18;14(1):14083. doi: 10.1038/s41598-024-64553-z.

本文引用的文献

1
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.手足综合征(HFS)的自我识别与管理:结构化教学计划对接受基于卡培他滨的结肠癌化疗患者的影响
Support Care Cancer. 2016 Jun;24(6):2575-81. doi: 10.1007/s00520-015-3061-6. Epub 2015 Dec 30.
2
Baseline quality of life factors predict long term survival after elective resection for colorectal cancer.基线生活质量因素可预测择期结直肠癌切除术后的长期生存情况。
Int J Surg Oncol. 2013;2013:269510. doi: 10.1155/2013/269510. Epub 2013 Nov 27.
3
Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer.
护士主导的电话干预是否可以替代护士主导的家庭护理和标准护理,用于接受口服卡培他滨的患者?一项针对结直肠癌患者的大型前瞻性审计的结果。
Eur J Cancer Care (Engl). 2013 May;22(3):413-9. doi: 10.1111/ecc.12047. Epub 2013 Mar 26.
4
Can a tailored telephone intervention delivered by volunteers reduce the supportive care needs, anxiety and depression of people with colorectal cancer? A randomised controlled trial.志愿者提供的个性化电话干预能否减少结直肠癌患者的支持性护理需求、焦虑和抑郁?一项随机对照试验。
Psychooncology. 2012 Oct;21(10):1053-62. doi: 10.1002/pon.2019. Epub 2011 Jul 18.
5
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.XELOX 对比 FOLFOX-4 一线治疗转移性结直肠癌:NO16966 更新结果。
Br J Cancer. 2011 Jun 28;105(1):58-64. doi: 10.1038/bjc.2011.201. Epub 2011 Jun 14.
6
A nurse-assisted screening and referral program for depression among survivors of colorectal cancer: feasibility study.护士辅助的结直肠癌幸存者抑郁筛查和转介计划:可行性研究。
Med J Aust. 2010 Sep 6;193(S5):S83-7. doi: 10.5694/j.1326-5377.2010.tb03935.x.
7
Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial.家庭护理计划在管理口服化疗的结直肠癌和乳腺癌患者症状方面的有效性:一项随机对照试验。
J Clin Oncol. 2009 Dec 20;27(36):6191-8. doi: 10.1200/JCO.2008.20.6755. Epub 2009 Nov 16.
8
A randomized study assessing the efficacy of communication skill training on patients' psychologic distress and coping: nurses' communication with patients just after being diagnosed with cancer.一项评估沟通技能培训对患者心理困扰及应对方式疗效的随机研究:护士在患者刚被诊断为癌症后与其进行的沟通。
Cancer. 2008 Sep 15;113(6):1462-70. doi: 10.1002/cncr.23710.
9
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.卡培他滨联合奥沙利铂(XELOX方案)与5-氟尿嘧啶/亚叶酸钙联合奥沙利铂(FOLFOX-4方案)作为转移性结直肠癌二线治疗的随机III期非劣效性研究
Ann Oncol. 2008 Oct;19(10):1720-6. doi: 10.1093/annonc/mdn370. Epub 2008 Jun 10.
10
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.卡培他滨联合奥沙利铂与氟尿嘧啶/亚叶酸钙联合奥沙利铂作为转移性结直肠癌一线治疗的随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2006-12. doi: 10.1200/JCO.2007.14.9898.